Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On June 30, 2014, AmpliPhi Biosciences Corporation (the "Company") appointed David Bosher to serve as the Company's interim Chief Financial Officer. Since October 1, 2013, Mr. Bosher is serving as Managing Director for Fahrenheit Advisors, a consulting and financial services company based in Richmond, Virginia. Prior to joining Fahrenheit, Mr. Bosher served from 2006 to 2013 as Senior Vice President and Chief Financial Officer of Snagajob.com, Inc., a leading human capital services and hourly employment network for job seekers and employers, headquartered in Richmond, Virginia. Prior to Snagajob, he served from 2001 to 2006 as Senior Vice President and Chief Financial Officer of Payerpath, Inc. a U.S.-based healthcare revenue cycle management software company based in Richmond, Virginia. From 1988 to 2001, Mr. Bosher served in various senior finance roles with Cadmus Communications Corporation (NMS:CDMS) and was Cadmus' Senior Vice President and Chief Financial Officer from 1999 to 2001. His work experience also includes having served as Director of Corporate Accounting at a major publicly traded pharmaceutical firm and as senior audit professional with a large regional public accounting firm. Mr. Bosher received a B.S. in Business, with a major in Accounting, and a Masters in Business Administration, from the University of Richmond.
Item 5.07. Submission of Matters to a Vote of Security Holders.
On June 27, 2014, the Company held its 2014 Annual Shareholders Meeting. The matters voted on at the meeting were: (1) the election of two Class II directors: Julian P. Kirk and Michael S. Perry; (2) ratification of the Board's appointment of PBMares, LLP as the Company's independent registered public accounting firm for the year ending December 31, 2014; and (3) the election of a third Class II director: Wendy S. Johnson. These matters are described in detail in the Company's proxy statement for the meeting, which was filed with the Securities and Exchange Commission on April 30, 2014, and amended in a filing made with the Securities and Exchange Commission on May 30, 2014. There were 182,535,562 shares of Common Stock and 8,859,978 shares of Series B Convertible Preferred Stock outstanding on the record date and entitled to vote at this meeting, for a total of 271,135,342 votes. Each of the directors up for election was elected and the PBMares, LLP was ratified as the Company's independent registered public accounting firm. The final voting results were as follows: Broker Matter For Against Withheld Non-votes 1. Election of Class II Directors (a) Julian P. Kirk 202,487,484 0 256,263 19,341,681 (b) Michael S. Perry 202,575,051 0 168,696 19,341,681 Matter For Against Abstain 2. Ratification of the appointment of PBMares, LLP 221,629,151 290,079 166,198 Broker Matter For Against Withheld Non-votes 3. Election of Class II Director (a) Wendy S. Johnson 180,012,712 52
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer